市场调查报告书
商品编码
1452953
全球微型电脑断层扫描 (CT) 市场 2024-2031Global Micro-Computed Tomography (CT) Market 2024-2031 |
预计在预测期内(2024-2031 年),全球微型 CT 市场将以 7.2% 的CAGR成长。该市场的成长归因于对高品质 3D 影像模式(如微型 CT)的需求不断增加,因为 3D 列印在医疗保健领域的使用不断扩大,特别是在手术规划、医疗设备生产和组织工程中。根据美国国立卫生研究院 (gov.) 的数据,到 2023 年 9 月,全球低收入和中等收入国家每年需要增加 1.43 亿例外科手术来拯救生命和预防残疾,然而,人工智慧在生产中的应用透过3D 列印製作器官模型,并强调了与实现高品质、高通量模型相关的挑战。将人工智慧和机器学习技术整合到积层製造 (AM) 中,有可能实现复杂资讯处理的自动化并协助做出合理决策,最终增强用于术前模拟的器官模型的开发。然而,目前将人工智慧与3D列印结合用于临床手术的研究有限,需要进一步改进以优化该过程的准确性和效率。
市场动态
Global Micro-Computed Tomography (CT) Market Size, Share & Trends Analysis Report by Product (In-Vivo and Ex-Vivo), by Application (Life Sciences, Bones, Dentistry, Plants and Food, Material Science, and Geology/Oil and Gas Geology), and by End-User (Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutions, and Pharmaceutical and Biotechnology Companies) Forecast Period (2024-2031)
Global micro-CT market is anticipated to grow at a CAGR of 7.2% during the forecast period (2024-2031). The market's growth is attributed to the need for high-quality 3D imaging modalities like micro-CT is increasing owing to the expanding usage of 3D printing in healthcare, particularly in surgery planning, medical device production, and tissue engineering. According to the National Institute of Health (gov.), in September 2023, globally, 143 million additional surgical procedures are needed each year in low- and middle-income countries to save lives and prevent disability however, the application of AI in the production of organs models through 3D printing and highlights the challenges associated with achieving high-quality, high-throughput models. The integration of AI and ML technology into additive manufacturing (AM) has the potential to automate complex information processing and assist in making rational decisions, ultimately enhancing the development of organ models for preoperative simulations. However, there is currently limited research on the use of AI combined with 3D printing for clinical procedures, and further advancements are needed to optimize the accuracy and efficiency of this process.
Market Dynamics
Growing Prevalence of High-Resolution Imaging
Micro-CT offers high-resolution imaging for precise diagnosis and early cancer detection. By visualizing specific tumor characteristics, it helps physicians define their goals and plan the course of action. According to the National Institute of Health, (gov.) in January 2023, Cancer is the globe's most significant cause of mortality, accounting for 10. million deaths and 19.3 million new diagnoses globally in 2020. Early detection rates and therapeutic management have improved with the use of diagnostic tools such as positron emission tomography (PET), computed tomography (CT), magnetic resonance spectroscopy (MRS), and molecular diagnostics. Nevertheless, obstacles include superior target definition and high expense rendering it complicated to diagnose deep-seated malignancies accurately. To improve cancer care, especially in low- and middle-income nations, to examine imaging, molecular, and inexpensive diagnostic technologies in this study.
Increasing the Use of Healthcare Applications
High-resolution imaging systems are expected to grow more and more in demand as micro-CT is used progressively in healthcare for preclinical research, orthodontic studies, and dental imaging. For instance, in May 2023, Nikon Metrology introduced the VOXLS 40 C 450, a large-volume CT system designed for inspection and analysis across various industries. It featured a granite-based manipulator, rigid steel towers, motors, and encoders, and two microfocus X-ray sources.
Market Segmentation
Ex-Vivo is Projected to Emerge as the Largest Segment
The ex-vivo sub-segment is expected to hold the largest share of the market owing to the increasing demand for high-resolution 3D visualization. According to the National Institute of Health (NIH.gov) survey published in September 2022, compared to other imaging modalities such as optical coherence tomography (OCT) and ultrasonography, micro-CT offers higher spatial resolution and precision in 3D imaging, enabling detailed characterization of ocular tissues and disease. Clinical ex-vivo imaging of ocular anatomy typically uses optical coherence tomography (OCT), magnetic resonance imaging (MRI), ocular ultrasonography, or fluorescence-based ophthalmoscopy. These methods offer fast and extensive investigations, though can reach resolutions down to 250 µm and 10 µm in depth. Hence, micro-CT is the preferred method for combining high-resolution imaging with 3D visualization on time. However, challenges include low radiodensity of untreated soft tissues and partial X-ray attenuation.
Diagnostic Laboratories Sub-segment to Hold a Considerable Market Share
The micro-CT systems are essential for materials science, metallurgy, and geology in both the commercial and academic domains. It improves failure analysis, process optimization, quality control, and materials characterization across a range of industries. For instance, in March 2021, Zeiss Research Microscopy Solutions introduced the Xradia CrystalCT micro-CT system, which enables 3D crystallographic imaging of polycrystalline materials for various applications in industrial and academic laboratories.
The global micro-computed tomography (CT) market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).
Explosive Growth of Biotechnology Industry in Asia-Pacific Region
North America Holds Major Market Share
Among all the regions, North America holds a significant share owing to the growing demand for advanced imaging technologies such as micro-CT is driven by the increasing geriatric population.The aging population, an increasing number of persistent diseases, the change in medical treatment toward image-guided treatments, and technology developments have been driving the market.
Furthermore, according to the National Institute of Health (gov.) in May 2022, chronic bone metabolic condition that increases the risk of fractures is low bone mineral density (LBMD), which includes osteoporosis and low bone mass. In the US, it affects more than 10 million people, and by 2020, 14 million individuals over 50 are predicted to be impacted. The most serious consequence is fractures, with a predicted 240% and 310% increase in hip fracture incidence by 2050. Patients with LBMD are more likely to experience fractures, with fragility fractures being the most common type.
The major companies serving the global micro computed tomography market include AggreDyne, Inc., Medtronic Pvt. Ltd., Siemens Healthineers Co., Sysmex Corp. Werfen, S.A., and others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in May 2023, Revvity launched three state-of-the-art imaging systems such as the Vega ultrasound system, the QuantumTM GX3 micro-CT structural imaging solution, and the IVIS Spectrum 2 and SpectrumCT 2. These innovations are expected to be on display in Prague at the World Molecular Imaging Congress.